ICOTYDE | Clinical Trials Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

13 results for “ICOTYDE”

Need more precision?

Filter by phase, recruitment status, country, sponsor, age, and study type.

Refine trial search

Not yet recruiting

ITMCTR2024000144

Auricular electroacupuncture for smoking cessation in young smokers with nicotine dependence: a randomized controlled trial

Not yet recruiting

ITMCTR2024000155

A study on the mechanism of auricular electroacupuncture on smoking cessation in young smokers

The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases

150 participants · First posted Sep 26, 2023

Correlation Study of Isotype Switching and Neutralizing Capacity to the COVID-19 Variants Strain

150 participants · First posted Oct 21, 2021

IRCT20220429054695N2

Quit smoking using the 5R method in a pharmacy

220 participants

Evaluation of Cyto-chex Tubes for the Measurement of Monocyte Expression of Human Leukocyte Antigen - DR Isotype (HLA-DR) Molecules by Flow Cytometry

40 participants · First posted Sep 21, 2022

A Phase 2, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer (mCRC)

46 participants · First posted Aug 5, 2022